Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtré par score tier "Moyen", market "China A-shares", market cap "Small <$2B" : 26 match(effacer les filtres).

#	Titre	Mkt Cap	Score▼	10Y ROE	Profit Streak	Net Debt/Eq	Gross Margin	Étude	FY
1	Guodian Nanjing Automation Co Ltd 600268 · Shanghai	$1.6B	64/100 Moyen	5.6%low 1.6%	10 yr+	Net cash	24%	—	FY2025
2	Ningbo Haitian Precision Machinery Co Ltd 601882 · Shanghai	$1.4B	64/100 Moyen	14.8%low 5.9%	10 yr+	Net cash	24%	—	FY2025
3	ZJMI Environmental Energy Co. Ltd. 603071 · Shanghai	$949M	64/100 Moyen	21.9%low 11.0%	7 yr	—	5%	—	FY2025
4	China Master Logistics Co Ltd 603967 · Shanghai	$557M	64/100 Moyen	14.7%low 8.9%	10 yr+	Net cash	7%	—	FY2025
5	Nanhua Futures Co Ltd 603093 · Shanghai	$1.9B	63/100 Moyen	7.7%low 3.3%	10 yr+	Net cash	100%	—	FY2025
6	Shanghai Ziyan Foods Co Ltd 603057 · Shanghai	$1.3B	63/100 Moyen	19.1%low 11.0%	6 yr	—	22%	—	FY2025
7	Zhejiang Noblelift Equip 603611 · Shanghai	$633M	63/100 Moyen	13.8%low 10.0%	10 yr+	0.2×	23%	—	FY2025
8	Aurisco Pharmaceutical Co Ltd 605116 · Shanghai	$1.1B	62/100 Moyen	14.1%low 6.5%	10 yr+	Net cash	52%	—	FY2025
9	Shanghai Bolex Food Technology Co. Ltd. 603170 · Shanghai	$733M	62/100 Moyen	22.0%low 17.0%	6 yr	—	32%	—	FY2025
10	Shanghai Holystar Information Technology Co. Ltd. A 688330 · Shanghai	$649M	62/100 Moyen	17.5%low 5.4%	10 yr+	Net cash	54%	—	FY2025
11	Jianmin Pharmaceutical Group Co Ltd 600976 · Shanghai	$614M	62/100 Moyen	13.4%low 6.4%	10 yr+	Net cash	40%	—	FY2025
12	Zhejiang Hangmin Co Ltd 600987 · Shanghai	$940M	61/100 Moyen	13.3%low 11.0%	10 yr+	Net cash	18%	—	FY2025
13	NanJing Pharmaceutical Co Ltd 600713 · Shanghai	$936M	60/100 Moyen	8.7%low 6.9%	10 yr+	0.4×	6%	—	FY2025
14	Giti Tire Corp 600182 · Shanghai	$619M	59/100 Moyen	10.2%low 3.3%	10 yr+	Net cash	17%	—	FY2025
15	Shanghai Zijiang Enterprise Group Co Ltd 600210 · Shanghai	$1.3B	57/100 Moyen	10.8%low 5.3%	10 yr+	0.2×	21%	—	FY2025
16	KTK Group Co Ltd 603680 · Shanghai	$1.1B	57/100 Moyen	13.5%low 4.1%	10 yr+	0.1×	29%	—	FY2025
17	Micro Tech Nanjing Co Ltd 688029 · Shanghai	$1.9B	56/100 Moyen	13.0%low -10.9%	9 yr	Net cash	66%	—	FY2025
18	Shanxi Huaxiang Group Co Ltd 603112 · Shanghai	$1.1B	56/100 Moyen	13.8%low 10.9%	10 yr+	0.0×	22%	—	FY2025
19	JiangXi Tianxin Pharm Co Ltd 603235 · Shanghai	$1.5B	55/100 Moyen	25.3%low 11.2%	6 yr	—	43%	—	FY2025
20	Nantong Jiangshan Agrochemical & Chemicals Co Ltd 600389 · Shanghai	$1.3B	54/100 Moyen	17.8%low 0.8%	10 yr+	0.0×	16%	—	FY2024
21	Chongqing Sanfeng Environment Group Corp Ltd 601827 · Shanghai	$2.0B	53/100 Moyen	11.5%low 9.3%	10 yr+	0.4×	29%	—	FY2025
22	Jiangxi Lianchuang Opto-electronic Science & Technology Co Ltd 600363 · Shanghai	$1.7B	53/100 Moyen	8.2%low 5.8%	10 yr+	Net cash	14%	—	FY2025
23	IKD Co Ltd Class A 600933 · Shanghai	$2.0B	52/100 Moyen	12.9%low 6.8%	10 yr+	0.1×	31%	—	FY2025
24	Shanghai Qiangsheng Holding Co Ltd 600662 · Shanghai	$1.5B	52/100 Moyen	10.5%low 2.2%	10 yr+	Net cash	12%	—	FY2025
25	Henan Thinker Automation 603508 · Shanghai	$1.2B	52/100 Moyen	7.5%low -14.9%	5 yr	Net cash	62%	—	FY2025
26	Qingdao Yunlu Advanced Materials Technology Co. Ltd. A 688190 · Shanghai	$1.2B	51/100 Moyen	14.6%low 6.5%	7 yr	—	28%	—	FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.